Genenta Science SPANASDAQ:GNTA
- LAST PRICE4.8000
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots2.5000/ 1
- Ask / Lots5.0000/ 3
- Open / Previous Close--- / 4.8000
- Day Range---
- 52 Week Range
- Volume---
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | GNTA |
|---|---|---|
| 10:06 ET | 200 | 5 |
| 11:21 ET | 1596 | 4.7 |
| 11:23 ET | 1800 | 4.6501 |
| 11:32 ET | 128 | 4.7 |
| 02:54 ET | 1369 | 4.8 |
Oct 23, 2024
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Genenta Science SPA | 87.8M | -9.4x | --- |
Regulus Therapeutics Inc | 91.7M | -1.3x | --- |
Annovis Bio Inc | 93.7M | -1.8x | --- |
Cabaletta Bio Inc | 91.3M | -0.9x | --- |
Hillevax Inc | 90.6M | -0.6x | --- |
Nuvectis Pharma Inc | 94.7M | -4.2x | --- |
Company Information
Genenta Science SpA is an Italy-based company engaged in clinical-stage biotechnology research. The Company focuses on the development of lentivirus-based gene and cell therapies in cancer. It uses gene-based cytokine delivery to activate the immune system within the tumor providing the anti-tumor response. The Company not only operates locally but also is present in global markets, including the United States.
Contact Information
- Headquarters
- Via Olgettina 58MILANO, Italy 20132
- Phone
- ---
- Fax
- ---
Executives
- Chairman of the Board, Chief Executive Officer
- Pierluigi Paracchi
- Chief Financial Officer
- Richard Slansky
- Finance Director
- Barbara Regonini
- Scientific Project Manager and Communication Officer
- Stefania Mazzoleni
- Chief Medical Officer, Head of Development
- Carlo Russo
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $87.8M |
|---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 18.3M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | --- |
EPS | $-0.51 |
Book Value | $1.17 |
P/E Ratio | -9.4x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
